74296-44-9 Usage
Uses
Used in Pharmaceutical Industry:
[5-(3,4-dichlorophenyl)-2,3-dihydro-1H-pyrrolizine-6,7-diyl]dimethanediyl bis(cyclobutylcarbamate) is used as a potential pharmaceutical compound for its possible applications in drug development. The presence of the 3,4-dichlorophenyl group and the cyclobutylcarbamate groups may provide unique properties that can be exploited in the design of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, [5-(3,4-dichlorophenyl)-2,3-dihydro-1H-pyrrolizine-6,7-diyl]dimethanediyl bis(cyclobutylcarbamate) may be utilized as a potential active ingredient in the development of new pesticides or herbicides. The specific functional groups in its structure could offer novel modes of action or selectivity against target pests or weeds.
Further Research:
Due to the complex nature of [5-(3,4-dichlorophenyl)-2,3-dihydro-1H-pyrrolizine-6,7-diyl]dimethanediyl bis(cyclobutylcarbamate), further research is necessary to fully understand its potential uses and properties. This may include studies on its chemical reactivity, stability, and biological activity, as well as potential toxicological and environmental impact assessments.
Check Digit Verification of cas no
The CAS Registry Mumber 74296-44-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,2,9 and 6 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 74296-44:
(7*7)+(6*4)+(5*2)+(4*9)+(3*6)+(2*4)+(1*4)=149
149 % 10 = 9
So 74296-44-9 is a valid CAS Registry Number.
74296-44-9Relevant academic research and scientific papers
Vinylogous carbinolamine tumor inhibitors. 7. Tumor inhibitory agents: bis-(N-alkylcarbamate) derivatives of 2,3-dihydro-5-(3',4'-dichlorophenyl)-6,7-bis(hydroxymethyl)-1H-pyrrolizine
Anderson,New,Corey
, p. 765 - 767 (2007/10/02)
A series of bis-(N-alkylcarbamate) derivatives of 2,3-dihydro-5-(3',4'-dichlorophenyl)-6,7-bis(hydroxymethyl-1H-pyrrolizine were prepared and evaluated for tumor inhibitory activity (in vivo P388 leukemia).
